Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 20 studies | 56% ± 21% | |
lung | 17 studies | 25% ± 7% | |
peripheral blood | 13 studies | 22% ± 6% | |
eye | 11 studies | 37% ± 14% | |
kidney | 7 studies | 22% ± 5% | |
intestine | 7 studies | 22% ± 9% | |
bone marrow | 5 studies | 23% ± 8% | |
uterus | 4 studies | 29% ± 15% | |
breast | 4 studies | 20% ± 2% | |
adipose | 4 studies | 30% ± 12% | |
pancreas | 3 studies | 55% ± 10% | |
heart | 3 studies | 16% ± 0% | |
liver | 3 studies | 37% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 41437.18 | 2640 / 2642 | 100% | 423.47 | 705 / 705 |
thymus | 100% | 10689.51 | 650 / 653 | 100% | 148.47 | 603 / 605 |
breast | 100% | 11544.86 | 457 / 459 | 99% | 164.92 | 1111 / 1118 |
uterus | 99% | 7237.28 | 168 / 170 | 100% | 104.89 | 458 / 459 |
bladder | 100% | 6287.05 | 21 / 21 | 98% | 95.92 | 495 / 504 |
lung | 98% | 7918.29 | 568 / 578 | 100% | 96.83 | 1154 / 1155 |
intestine | 99% | 7704.45 | 953 / 966 | 99% | 94.93 | 522 / 527 |
skin | 100% | 11465.96 | 1803 / 1809 | 98% | 76.37 | 462 / 472 |
esophagus | 97% | 6327.76 | 1396 / 1445 | 100% | 81.50 | 183 / 183 |
pancreas | 94% | 5704.27 | 307 / 328 | 100% | 97.10 | 178 / 178 |
ovary | 91% | 4893.97 | 163 / 180 | 100% | 133.89 | 430 / 430 |
stomach | 85% | 5064.21 | 306 / 359 | 100% | 88.12 | 286 / 286 |
adrenal gland | 88% | 6666.69 | 226 / 258 | 96% | 132.67 | 221 / 230 |
kidney | 83% | 5196.75 | 74 / 89 | 99% | 91.59 | 891 / 901 |
prostate | 80% | 4161.22 | 197 / 245 | 99% | 89.81 | 498 / 502 |
liver | 54% | 2847.56 | 121 / 226 | 99% | 71.73 | 403 / 406 |
adipose | 100% | 13913.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 82.55 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 57.29 | 1 / 1 |
blood vessel | 99% | 7949.29 | 1320 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 24500.65 | 907 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 47.73 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 96% | 52.47 | 77 / 80 |
spleen | 88% | 5773.26 | 213 / 241 | 0% | 0 | 0 / 0 |
muscle | 78% | 4676.59 | 625 / 803 | 0% | 0 | 0 / 0 |
heart | 58% | 3046.21 | 499 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007420 | Biological process | brain development |
GO_0006915 | Biological process | apoptotic process |
GO_0071786 | Biological process | endoplasmic reticulum tubular network organization |
GO_0071787 | Biological process | endoplasmic reticulum tubular network formation |
GO_0030182 | Biological process | neuron differentiation |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_1902430 | Biological process | negative regulation of amyloid-beta formation |
GO_0005615 | Cellular component | extracellular space |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0014069 | Cellular component | postsynaptic density |
GO_0043005 | Cellular component | neuron projection |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | RTN3 |
Protein name | Truncated RTN3-A3 Reticulon-3 (Homolog of ASY protein) (HAP) (Neuroendocrine-specific protein-like 2) (NSP-like protein 2) (Neuroendocrine-specific protein-like II) (NSP-like protein II) (NSPLII) Reticulon 3 Reticulon |
Synonyms | ASYIP hCG_1775344 NSPL2 |
Description | FUNCTION: May be involved in membrane trafficking in the early secretory pathway. Inhibits BACE1 activity and amyloid precursor protein processing. May induce caspase-8 cascade and apoptosis. May favor BCL2 translocation to the mitochondria upon endoplasmic reticulum stress. Induces the formation of endoplasmic reticulum tubules . Also acts as an inflammation-resolving regulator by interacting with both TRIM25 and RIGI, subsequently impairing RIGI 'Lys-63'-linked polyubiquitination leading to IRF3 and NF-kappa-B inhibition. .; FUNCTION: (Microbial infection) Plays a positive role in viral replication and pathogenesis of enteroviruses. . |
Accessions | ENST00000540798.5 [O95197-7] F5H617 ENST00000543552.5 ENST00000339997.8 [O95197-2] B7Z4M1 ENST00000341307.6 [O95197-5] O95197 ENST00000377819.10 [O95197-1] Q7RTN4 ENST00000536011.5 ENST00000356000.7 [O95197-4] ENST00000542238.5 ENST00000354497.4 [O95197-6] ENST00000537981.5 [O95197-3] F5GWG7 ENST00000545432.5 F5H891 |